Kamal Fariborz 4
4 · 4D Molecular Therapeutics, Inc. · Filed Mar 10, 2025
Insider Transaction Report
Form 4
Kamal Fariborz
President & COO
Transactions
- Award
Stock Option (Right to Buy)
2025-03-06+178,400→ 178,400 totalExercise: $4.14Exp: 2035-03-05→ Common Stock (178,400 underlying)
Footnotes (1)
- [F1]The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of March 6, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.